Plasma osteopontin levels in multiple sclerosis.

作者: Manuel Comabella , Imma Pericot , Robert Goertsches , Carlos Nos , Mireia Castillo

DOI: 10.1016/J.JNEUROIM.2004.09.004

关键词:

摘要: Abstract Osteopontin (OPN) is a pleiotropic integrin binding protein with functions in cell-mediated immunity, inflammation, tissue repair, and cell survival. Recent studies have shown that OPN may play an important role the pathogenesis of experimental autoimmune encephalomyelitis multiple sclerosis (MS). Here, we investigated plasma levels 221 MS patients 36 healthy controls using enzyme-linked immunoassay. The group comprised 71 primary transitional progressive (PP/TP-MS), 35 secondary (SPMS), 115 relapsing–remitting (RRMS)[46 during clinical remission, 26 relapse, 43 treated interferon-beta (IFNβ)]. Levels were elevated SPMS compared controls, RRMS PP/TP-MS patients. Patients relapse presented higher than remission. When classified based on progression neurological disability, inverse relation between disability was observed only relapsing MS. In receiving therapy IFNβ, similar to These findings suggest involved both acute chronic disease activity, thus expanding suggested by previous studies. Furthermore, different profiles found relapses its apparent lack influence phenotypes raise interesting questions actual

参考文章(52)
Marianne Jansson, Vily Panoutsakopoulou, Jessica Baker, Ludger Klein, Harvey Cantor, Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice Journal of Immunology. ,vol. 168, pp. 2096- 2099 ,(2002) , 10.4049/JIMMUNOL.168.5.2096
Uriel M. Malyankar, Marta Scatena, Katherine L. Suchland, Theodore J. Yun, Edward A. Clark, Cecilia M. Giachelli, Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells Journal of Biological Chemistry. ,vol. 275, pp. 20959- 20962 ,(2000) , 10.1074/JBC.C000290200
Marina Saresella, Antonino Salvaggio, Gregorio Aversa, Mara Biasin, Daria Trabattoni, Pasquale Ferrante, Mario Clerici, Carlo L. Cazzullo, Enrico Clerici, Maria Luisa Fusi, Domenico Caputo, Jan E. de Vries, Cytokine Production and Surface Marker Expression in Acute and Stable Multiple Sclerosis: Altered IL-12 Production and Augmented Signaling Lymphocytic Activation Molecule (SLAM)-Expressing Lymphocytes in Acute Multiple Sclerosis Journal of Immunology. ,vol. 160, pp. 1514- 1521 ,(1998)
Anthony O'Regan, Jeffrey S. Berman, Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation International Journal of Experimental Pathology. ,vol. 81, pp. 373- 390 ,(2001) , 10.1046/J.1365-2613.2000.00163.X
Thomas E. Lane, Jean E. Merrill, Louis J. Ignarro, Michael P. Sherman, Judy Melinek, Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. Journal of Immunology. ,vol. 151, pp. 2132- 2141 ,(1993)
Cecilia M. Giachelli, Charles E. Murry, Donna Lombardi, Richard J. Johnson, Manuela Almeida, Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo American Journal of Pathology. ,vol. 152, pp. 353- 358 ,(1998)
Cecilia M. Giachelli, Charles E. Murry, Stephen M. Schwartz, Rudolf Vracko, Macrophages express osteopontin during repair of myocardial necrosis. American Journal of Pathology. ,vol. 145, pp. 1450- 1462 ,(1994)
Jackie Palace, Clinical and laboratory characteristics of secondary progressive MS. Journal of the Neurological Sciences. ,vol. 206, pp. 131- 134 ,(2003) , 10.1016/S0022-510X(02)00419-7
A. Oldberg, A. Franzen, D. Heinegard, Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 8819- 8823 ,(1986) , 10.1073/PNAS.83.23.8819
Jan Philippé, Jan Debruyne, Geert Leroux-Roels, Annick Willems, Jacques Dereuck, In vitro TNF-α, IL-2 and IFN-γ production as markers of relapses in multiple sclerosis Clinical Neurology and Neurosurgery. ,vol. 98, pp. 286- 290 ,(1996) , 10.1016/0303-8467(96)00041-8